EMA Tightens Links With Academia To Boost Innovation And Regulatory Science

A new framework for interactions between the EMA and the academic community is expected to foster innovation in new drugs and evaluation methodologies, by keeping the agency in touch with cutting-edge research and giving academics the chance to benefit more from the expertise in the EU regulatory network.

Scientist conducting a laboratory experiment in a cancer research facility in the United States, 1951.
The EMA wants to build stronger links with academia to boost innovation and regulatory science

The European Medicines Agency has outlined a set of actions to be taken over the next three years to strengthen its relations with academia, as part of an initiative that the agency says will help it keep up with relevant scientific developments while giving academic start-ups regulatory advice on how to turn their research into new medicines.

The new framework for interactions between the EMA and the academic community aims to raise awareness among academia...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from R&D

More from Pink Sheet